Tue, 20th Apr 2021 15:12
April 20 (Reuters) - Europe's drug regulator has found a
possible link between Johnson & Johnson's COVID-19
vaccine and rare blood clotting issues in adults who had
received the shot in the United States, the watchdog said on
Tuesday.
(Reporting by Pushkala Aripaka in Bengaluru
Editing by David Goodman)
(Correcting company name in headline)
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...
Astrazeneca (AZN)